Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment
Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine, a novel antimalarial compound being developed as a potential single-dose treatment for malaria....
NORROY’s 68Ga-NYM096 Receives FDA Breakthrough Therapy and Fast Track Designations
Norroy bioscience, a clinical-stage biotechnology company focused on targeted radiopharmaceuticals, has announced that the US Food and Drug Administration (FDA) has granted Breakthrough...
RiboX Wins FDA IND Clearance for circRNA CAR-T Therapy
RiboX Therapeutics has received U.S. Food and Drug Administration (FDA) clearance for the Investigational New Drug (IND) application for RXIM002, an investigational circular RNA (circRNA)-based in vivo CAR-T therapy....
Lilly’s Olomorasib Gains FDA Breakthrough Therapy Status
Eli Lilly and Company has secured Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for olomorasib, an investigational medicine being developed for adults with advanced pancreatic cancer carrying a KRAS G12C mutation....
Takeda Secures FDA Approval for ORZEYFUL in Narcolepsy Type 1
Takeda has secured US Food and Drug Administration (FDA) approval for ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist for treating narcolepsy type 1 (NT1) in adults....
Allogene’s Cema-cel Gains FDA Fast Track and RMAT Designations for LBCL Treatment
Allogene Therapeutics has announced that its investigational allogeneic CAR T-cell therapy, cemacabtagene ansegedleucel (cema-cel), has received Regenerative Medicine Advanced...
University of Queensland Researchers Unlock New Drug Target for Neurodegenerative Disease Therapies
University of Queensland (UQ) researchers have developed a novel drug molecule that targets the hard-to-study immune receptor C5aR2, opening new possibilities for treatments targeting neurodegenerative diseases such as Motor Neurone Disease (MND)....
Merck Secures FDA Approval for First Oral PCSK9 Inhibitor LIPFENDRA to Treat High LDL Cholesterol
Merck has received approval from the US Food and Drug Administration (FDA) for LIPFENDRA® (enlicitide) 20 mg, making it the first oral PCSK9 inhibitor authorised in the United States....
Orca Bio Gains FDA Approval for TREGZI to Improve Stem Cell Transplant Outcomes
Orca Bio has received approval from the U.S. Food and Drug Administration (FDA) for TREGZI™ (allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq), a precision-engineered...
Kowa’s K-808 Receives FDA Breakthrough Therapy Designation for Primary Biliary Cholangitis
Kowa Company has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to its investigational therapy, K-808 (pemafibrate), for the treatment of primary biliary cholangitis (PBC)....
